300 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Bedel Financial Consulting Inc.

Bedel Financial Consulting Inc. bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, HoldingsChannel reports. The firm bought 300 shares of the biotechnology company’s stock, valued at approximately $178,000.

Several other institutional investors and hedge funds also recently bought and sold shares of AXON. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth $40,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the 4th quarter worth about $45,000. Prestige Wealth Management Group LLC raised its stake in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $53,000. Finally, GPS Wealth Strategies Group LLC grew its stake in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after buying an additional 40 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $528.28 on Wednesday. The stock has a 50-day simple moving average of $607.58 and a 200 day simple moving average of $526.43. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The stock has a market capitalization of $40.28 billion, a PE ratio of 136.51, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insiders Place Their Bets

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock valued at $3,262,847 in the last three months. Company insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of several recent research reports. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective for the company. in a research note on Thursday, February 20th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.